» Articles » PMID: 19808980

BH3-only Proteins Mcl-1 and Bim As Well As Endonuclease G Are Targeted in Spongistatin 1-induced Apoptosis in Breast Cancer Cells

Overview
Journal Mol Cancer Ther
Date 2009 Oct 8
PMID 19808980
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Spongistatin 1, a marine experimental substance with chemotherapeutic potential, induces apoptosis and inhibits clonogenic survival of MCF-7 cells. Regarding the apoptotic signaling pathways of spongistatin 1, we present two major facts. Firstly, spongistatin 1-induced cell death, mainly caspase-independent, involves the proapoptotic proteins apoptosis-inducing factor and endonuclease G. Both proteins translocate from mitochondria to the nucleus and contribute to spongistatin 1-mediated apoptosis as shown via gene silencing. Secondly, spongistatin 1 acts as a tubulin depolymerizing agent and is able to free the proapoptotic Bcl-2 family member Bim from its sequestration both by the microtubular complex and by the antiapoptotic protein Mcl-1. Silencing of Bim by small interfering RNA leads to a diminished translocation of apoptosis-inducing factor and endonuclease G to the nucleus and subsequently reduces apoptosis rate. Thus, we identified Bim as an important factor upstream of mitochondria executing a central role in the caspase-independent apoptotic signaling pathway induced by spongistatin 1. Taken together, spongistatin 1 is both a valuable tool for the characterization of apoptotic pathways and a promising experimental anticancer drug.

Citing Articles

Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.

Chaudhry G, Md Akim A, Sung Y, Sifzizul T Front Pharmacol. 2022; 13:842376.

PMID: 36034846 PMC: 9399632. DOI: 10.3389/fphar.2022.842376.


Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.

Patra S, Praharaj P, Panigrahi D, Panda B, Bhol C, Mahapatra K Mol Biol Rep. 2020; 47(9):7209-7228.

PMID: 32797349 DOI: 10.1007/s11033-020-05709-8.


Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds.

Fan M, Nath A, Tang Y, Choi Y, Debnath T, Choi E Mar Drugs. 2018; 16(5).

PMID: 29757237 PMC: 5983291. DOI: 10.3390/md16050160.


Marine Sponge Natural Products with Anticancer Potential: An Updated Review.

Calcabrini C, Catanzaro E, Bishayee A, Turrini E, Fimognari C Mar Drugs. 2017; 15(10).

PMID: 29027954 PMC: 5666418. DOI: 10.3390/md15100310.


Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem".

Gomes N, Dasari R, Chandra S, Kiss R, Kornienko A Mar Drugs. 2016; 14(5).

PMID: 27213412 PMC: 4882572. DOI: 10.3390/md14050098.